Form 8-K Deciphera Pharmaceutical For: Aug 13
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 13, 2019
DECIPHERA PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware 001-38219 30-1003521
(State or other jurisdiction
500 Totten Pond Road
Waltham, MA 02451 (Address of registrant’s principal executive office) (Zip code)
(Registrant’s telephone number, including area code)